References
- Miravitlles M, Dirksen A, Ferrarotti I, et al. European Respiratory Society statement: diagnosis and treatment of pulmonary disease in alpha1-antitrypsin deficiency. Eur Respir J. 2017;50(5):1700610. DOI:10.1183/13993003.00610-2017
- Laurell CB, Eriksson S. The electrophoretic α;1-globulin pattern of serum in α;1-antitrypsin deficiency. Scand J Clin Lab Invest. 1963;15(2):132–140. DOI:10.3109/00365516309051324
- PubMed.gov [Internet]. Bethesda (MD): National Center for Biotechnology Information; [cited 2020 June 11]. Available from: https://pubmed.ncbi.nlm.nih.gov/.
- Kueppers F, Andrake MD, Xu Q, et al. Protein modeling to assess the pathogenicity of rare variants of SERPINA1 in patients suspected of having Alpha 1 Antitrypsin Deficiency. BMC Med Genet. 2019;20(1):125. DOI:10.1186/s12881-019-0852-5
- Stockley RA. The multiple facets of alpha-1-antitrypsin. Ann Transl Med. 2015;3(10):130. DOI:10.3978/j.issn.2305-5839.2015.04.25
- Sanders CL, Ponte A, Kueppers F. The effects of inflammation on alpha 1 antitrypsin levels in a national screening cohort. COPD. 2018;15(1):10–16. DOI:10.1080/15412555.2017.1401600
- Ferrarotti I, Thun GA, Zorzetto M, et al. Serum levels and genotype distribution of α1-antitrypsin in the general population . Thorax. 2012;67(8):669–674. DOI:10.1136/thoraxjnl-2011-201321
- Gulhar R, Ashraf MD, Jialal I. Physiology, acute phase reactants. Treasure Island (FL): StatPearls Publishing; 2020.
- Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805–1812. DOI:10.1172/JCI18921
- Ciubotaru I, Potempa LA, Wander RC. Production of modified C-reactive protein in U937-derived macrophages. Exp Biol Med (Maywood)). 2005;230(10):762–770. NovDOI:10.1177/153537020523001010
- Ottaviani S, Gorrini M, Scabini R, et al. C reactive protein and alpha1-antitrypsin: relationship between levels and gene variants. Transl Res. 2011;157(6):332–338. DOI:10.1016/j.trsl.2010.12.014
- Zorzetto M, Russi E, Senn O, et al. SERPINA1 gene variants in individuals from the general population with reduced alpha1-antitrypsin concentrations. Clin Chem. 2008;54(8):1331–1338. AugDOI:10.1373/clinchem.2007.102798
- Senn O, Russi EW, Schindler C, et al. Circulating alpha1-antitrypsin in the general population: determinants and association with lung function. Respir Res. 2008;9:35. DOI:10.1186/1465-9921-9-35
- Kueppers F. Genetically determined differences in the response of alpha-antitrypsin levels in human serum to typhoid vaccine. Humangenetik. 1968;6(3):207–214. DOI:10.1007/BF00291864
- American Thoracic Society and the European Respiratory Society. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003;168(7):818–900.
- Iorio A, Keepanasseril A, Foster G, et al. Development of a web-accessible population pharmacokinetic service-hemophilia (WAPPS-Hemo): study protocol. JMIR Res Protoc. 2016;5(4):e239. DOI:10.2196/resprot.6558
- WAPPS-HEMO.org [Internet]. Hamilton (ON): McMaster University; [cited 2020 June 11]. Available from: https://www.wapps-hemo.org/.